Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Jyothy Lab - Q3FY21 First Cut - ICICI Direct

Posted On: 2021-01-27 09:07:56 (Time Zone: Arizona, USA)


(CMP - Rs. 155, MCap - Rs. 5,708 crore)

Jyothy lab posted strong results in Q3FY21 with 15.3% sales growth & 22.8% earnings growth.

Q3FY21 Earnings Summary

- Standalone Revenue grew by 15.3% to Rs. 469.4 crore led by 15% volume growth. Dishwashing, Personal care & Household Insecticide segments witnessed a robust 21.1%, 48.2% & 10% revenue growth whereas fabric care business saw dismal 2.3% growth during the quarter. The healthy growth is dishwashing segment was led by prominence of smaller packs in rural regions. Further consumption shift from unbranded (local products) to branded have accelerated in FY21, which helped Jyothy Lab in growing its brands. The strong growth in personal care segment has been on account of increasing preferences of natural products & focus on distribution of relatively newer launched products (face wash, hand wash & sanitizers)

- Gross margins improved by 67 bps largely due to benign crude based raw material cost. The company has increased its advertisement spend by 43.5% to Rs. 35.1 crore (147 bps higher as % of sales) in Q3 whereas it has been able to save similar 143 bps on overhead spends resulting in operating profit growth of 22.6% to Rs. 79.8 crore. Operating margins expanded by 102 bps to 17%.

- Led by strong growth in operating profit & lower interest cost, Net profit increased by 22.8% to Rs. 52.2 crore

Jyothy lab has been benefited by significant increase in rural spends in FY21 mainly led by higher government spend post pandemic. Moreover, benign raw material cost helped in improving operating margins. Out of the four major segments, Dishwashing & Personal care has seen a strong sustainable growth in last few years with increasing rural penetration of company's brand (Pril & Exo, Margo). Fabric whitener category has been saturated & has been growing only in selected regions in South India. Despite household insecticide is growing at a faster pace post pandemic period, it is still a loss making category for the company due to higher product concentration on Coils. We believe the structural growth in matured category would require higher advertisement spends on sustainable basis, which would cap operating margins at current levels. We will review our recommendation & target price.

We will be coming out with detailed update after the conference call with the management.

Shares of JYOTHY LABORATORIES LTD. was last trading in BSE at Rs.151.9 as compared to the previous close of Rs. 157.65. The total number of shares traded during the day was 57333 in over 1687 trades.

The stock hit an intraday high of Rs. 159.2 and intraday low of 150.4. The net turnover during the day was Rs. 8849671.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Initiating Coverage - Mastek Ltd - HDFC Securities Retail Research Desk

Hindalco Industries - Status quo maintained - ICICI Securities

Tata Motors - India business scaling in the right direction - ICICI Securities

IPO Review - Heranba Industries Ltd

Company Update - Narayana Hrudayalaya - ICICI Direct

Ambuja Cements - Market share sustenance key for rerating - ICICI Securities

ADD on Astral Poly Technik - An 'astr'onomical growth story - HDFC Securities

FMCG Sector Update Report - Divergence narrows; refocus on core - HDFC Securities

Maintain REDUCE on Jubilant FoodWorks - More legs for growth; reflecting confidence on core - HDFC Securities

Torrent Power - Growth acceleration - ICICI Securities

Mahindra CIE Automotive - CY20 performance closes on a strong note - ICICI Securities

Q3FY21 Company Update - V-Guard Industries - ICICI Direct

Quant Pick - Indus Towers - ICICI Direct

Q4CY20 Result Update - Ambuja Cement - ICICI Direct

Q3FY21 Company Update - Nesco Ltd - ICICI Direct

Maintain BUY on Ambuja Cements - Healthy quarter; multiple triggers ahead - HDFC Securities

Heranba Industries Ltd. - IPO - Sound Financials & Promising Outlook Augur Well

India Equity Strategy Report - Quarterly flipbook: Q3 - upgrades galore! - HDFC Securities

Earnings Wrap Q3FY21: Encouraging quarter, broad based recovery under way!

Shilpa Medicare - USFDA import alert at Jadcherla unit - ICICI Securities

Q3FY21 Company Update - Indian Bank - ICICI Direct

Quant Pick - Torrent Power - ICICI Direct

GE T&D India - Strong cashflow - ICICI Securities

Q3FY21 Result Update - Graphite India - ICICI Direct

Q4CY2020 Result Update - Varun Beverages - ICICI Direct

Q3FY21 Company Update - NBCC Ltd - ICICI Direct

Quant Pick - United Breweries - ICICI Direct

Q4CY2020 Result Update - Nestlé India - ICICI Direct

Q3FY21 Result Update - Time Technoplast - ICICI Direct

Healthy Business Performance Puts ITC Stock Recovery on Track

Gold - Feb 17, 2021 - Reliance Securities

Maintain REDUCE on Nestle India - Steady revenue show; employee cost dents margins - HDFC Securities

Varun Beverages - Q4 CY20 Result and Concall Update - YES Securities

Nestle India - Q4 CY20 Result Update - YES Securities

Reiterate BUY on JMC Projects - Some hits, some misses - HDFC Securities

Varun Beverages - Strong volumes; higher margins - ICICI Securities

Computer Age Management Services - Play on industry AUM growth - ICICI Securities

Nestle India - Just a tad underwhelming (given the high benchmarks expected from Nestle India) - ICICI Securities

NHPC - Earnings robust; projects on track - ICICI Securities

Maintain BUY on ITD Cementation - Gradual recovery shaping up - HDFC Securities

Techno Electric & Engineering - Strong margins, healthy growth outlook - ICICI Securities

Time Technoplast - Outlook upbeat; execution remains key - ICICI Securities



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020